Sort by
Refine Your Search
-
collaboration in their research and exemplifies founder Arnold Beckman's vision. Senior Fellows Program The Senior Fellows Program offers two application cycles per year. It allows established (post PhD) faculty
-
. With this vision as our guide, the school is dedicated to developing and fostering a community of global leaders advancing oral and systemic health. HSDM offers a unique interdisciplinary environment for
-
of practice curriculum, session design, learning materials, monthly virtual sessions, and annual in-person convenings Supervise the Institute for Success Planning’s Senior Program Coordinator, program staff
-
, macular degeneration, and glaucoma, has appointed John S. Penn, PhD, a renowned vision scientist and professor at Vanderbilt University Medical Center, and Dale Young, chairman and CEO of Summit Financial
-
prototyping, and production-ready solutions. Translate cutting-edge AI research into practical applications, optimizing LLMs, multi-agent systems, and computational tools. Develop and refine AI-powered tools
-
made valuable contributions resulting in co-authorship in high-impact publications and have successfully moved on to MD and/or PhD programs as well as industry positions. Responsibilities will include
-
23-Apr-2025 Harvard Business School 68117BR Job Summary The Program Coordinator works alongside another Program Coordinator and Program Manager to make up an Executive Education Program Delivery
-
Qualifications Bachelor’s degree or equivalent work experience required Minimum of 7 years’ relevant work experience Additional Qualifications and Skills PhD strongly preferred and experience advising students
-
research. With this vision as our guide, the school is dedicated to developing and fostering a community of global leaders advancing oral and systemic health. HSDM offers a unique interdisciplinary
-
diseases. You thrive in a fast-paced work environment. About the Role: The Wyss Institute’s Brain Targeting Program (BTP), co-led by James Gorman, M.D., Ph.D. and Donald Ingber, M.D., Ph.D., is developing